Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02900664
Title A Study of PDR001 in Combination With CJM112, EGF816, Ilaris (Canakinumab) or Mekinist (Trametinib)
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors Novartis Pharmaceuticals
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | ITA | FRA | ESP | CAN | BEL

Facility Status City State Zip Country Details
Sidney Kimmel Comprehensive Cancer Center SC-3 Baltimore Maryland 21287-0013 United States Details
Dana Farber Cancer Center Boston Massachusetts 02215 United States Details
Sarah Cannon Research Institute Nashville Tennessee 37203 United States Details
University of Texas MD Anderson Cancer Center Houston Texas 77030 United States Details
Novartis Investigative Site Brussels BE-B-1200 Belgium Details
Novartis Investigative Site Wilrijk 2610 Belgium Details
Novartis Investigative Site Toronto Ontario M5G 2M9 Canada Details
Novartis Investigative Site Montreal Quebec H3T 1E2 Canada Details
Novartis Investigative Site Lyon Cedex 69373 France Details
Novartis Investigative Site Paris 75231 France Details
Novartis Investigative Site Toulouse Cedex 9 31059 France Details
Novartis Investigative Site Villejuif Cedex 94800 France Details
Novartis Investigative Site Tel Aviv 6423906 Israel Details
Novartis Investigative Site Milano MI 20132 Italy Details
Novartis Investigative Site Rozzano MI 20089 Italy Details
Novartis Investigative Site Singapore 119228 Singapore Details
Novartis Investigative Site Singapore 169610 Singapore Details
Novartis Investigative Site Barcelona Catalunya 08036 Spain Details
Novartis Investigative Site Hospitalet de LLobregat Catalunya 08907 Spain Details
Novartis Investigative Site Madrid 28009 Spain Details
Novartis Investigative Site Madrid 28050 Spain Details
Novartis Investigative Site Tainan 70403 Taiwan Details
Novartis Investigative Site Taoyuan 33305 Taiwan Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field